Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices
- PMID: 19096883
- DOI: 10.1007/s00520-008-0561-7
Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices
Abstract
Goals: Central venous catheter (CVC)-related bloodstream infection (CR-BSI) is a significant complication in hematology patients. A range of CVC devices may be used, and risks for the development of complications are not uniform. The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population.
Patients and methods: An observational cohort of patients with hematologic malignancy was prospectively studied following CVC insertion. Participants were reviewed until a CVC-related complication necessitated device removal, completion of therapy, death, or defined end-of-study date. The National Nosocomial Infection Surveillance definition for CR-BSI was used. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured.
Main results: One hundred six CVCs (75 peripherally inserted central venous catheters [PICCs], 31 nontunneled CVCs) were evaluated in 66 patients, over 2,399 CVC days. Thrombosis occurred in 16 cases (15.1%), exit-site infection in two (1.9%), and CR-BSI in 18 (7.5 per 1,000 CVC days). No significant differences were found when complication rates in PICC and nontunneled devices were compared. An underlying diagnosis of acute myeloid leukemia was negatively associated with CR-BSI (odds ratio (OR) 0.14, p = 0.046), and a previous diagnosis of fungal infection was associated with infection (OR 22.82, p = 0.031).
Conclusions: CR-BSI rates in our hematology population are comparable to prior reports. A low rate of exit-site infection and high proportion of thrombotic complications were observed. No significant differences in thrombotic or infective complications were evident when PICC and nontunneled devices were compared. PICC devices are a practical and safe option for management of hematology patients.
Similar articles
-
A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.Int J Hematol. 2014 Dec;100(6):592-8. doi: 10.1007/s12185-014-1677-9. Epub 2014 Sep 24. Int J Hematol. 2014. PMID: 25248408
-
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):e184-e194. doi: 10.1016/j.clml.2018.12.008. Epub 2018 Dec 20. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30704933 Clinical Trial.
-
Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units.Surg Infect (Larchmt). 2011 Aug;12(4):279-82. doi: 10.1089/sur.2008.058. Epub 2010 Jul 14. Surg Infect (Larchmt). 2011. PMID: 20629557 Clinical Trial.
-
The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.Mayo Clin Proc. 2006 Sep;81(9):1159-71. doi: 10.4065/81.9.1159. Mayo Clin Proc. 2006. PMID: 16970212 Review.
-
Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients.Chest. 2005 Aug;128(2):489-95. doi: 10.1378/chest.128.2.489. Chest. 2005. PMID: 16100130 Review.
Cited by
-
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).Support Care Cancer. 2015 Nov;23(11):3289-95. doi: 10.1007/s00520-015-2740-7. Epub 2015 Apr 26. Support Care Cancer. 2015. PMID: 25910751
-
Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia.Ann Hematol. 2021 Nov;100(11):2825-2830. doi: 10.1007/s00277-021-04673-y. Epub 2021 Sep 30. Ann Hematol. 2021. PMID: 34591161
-
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy.Bone Marrow Transplant. 2021 Jan;56(1):195-201. doi: 10.1038/s41409-020-01003-0. Epub 2020 Jul 23. Bone Marrow Transplant. 2021. PMID: 32704092
-
A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.Int J Hematol. 2014 Dec;100(6):592-8. doi: 10.1007/s12185-014-1677-9. Epub 2014 Sep 24. Int J Hematol. 2014. PMID: 25248408
-
Venue of catheter insertion does not significantly impact the event of central line-associated bloodstream infection in patients with haematological diseases.Infect Prev Pract. 2020 Mar 4;2(2):100050. doi: 10.1016/j.infpip.2020.100050. eCollection 2020 Jun. Infect Prev Pract. 2020. PMID: 34368700 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical